177 related articles for article (PubMed ID: 17483491)
1. Invasive cervical cancer: a failure of screening.
Spayne J; Ackerman I; Milosevic M; Seidenfeld A; Covens A; Paszat L
Eur J Public Health; 2008 Apr; 18(2):162-5. PubMed ID: 17483491
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
5. Pap smear screening and invasive cervical cancer.
Brown RK; Barker WH
J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
[TBL] [Abstract][Full Text] [Related]
6. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
8. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening and the older woman: obstacles and opportunities.
Brooks SE
Cancer Pract; 1996; 4(3):125-9. PubMed ID: 8826140
[TBL] [Abstract][Full Text] [Related]
10. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
12. An audit of the cervical cancer screening histories of 246 women with carcinoma.
Duggan MA; Nation J
J Low Genit Tract Dis; 2012 Jul; 16(3):263-70. PubMed ID: 22297213
[TBL] [Abstract][Full Text] [Related]
13. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
14. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of cervical cancer in women age sixty and over.
Fox KV; Shah CA; Swisher EM; Garcia RL; Mandel LS; Gray HJ; Swensen RE; Goff BA
Gynecol Oncol; 2008 Apr; 109(1):53-8. PubMed ID: 18255127
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
17. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
[TBL] [Abstract][Full Text] [Related]
18. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
19. Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.
Obi SN; Ozumba BC; Nwokocha AR; Waboso PA
J Obstet Gynaecol; 2007 Apr; 27(3):305-7. PubMed ID: 17464818
[TBL] [Abstract][Full Text] [Related]
20. Organization of screening in technically advanced countries: Iceland.
Geirsson G
IARC Sci Publ; 1986; (76):239-50. PubMed ID: 3570408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
